Oral antiviral drug reduces death risk by 50% in COVID-19 patient
October 2, 2021
No deaths reported through day 29 in patients who received Molnupiravir drug, study shows
An oral antiviral treatment drug reduced the risk of hospitalization or death by around 50% in COVID-19 patients, Merck and Ridgeback Biotherapeutics announced on Fr...